Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast Cancer

Condition:   Triple Negative Breast Cancer Interventions:   Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Doxorubicin;   Drug: Cyclophosphamide Sponsor:   University of Illinois at Chicago Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials